LivingGLP1
Study S002562

A Randomized, Double-Blind Crossover Trial to Assess Gastrointestinal Responses to Dietary Fibers in Adults Using Weight Loss Medications

Registration

Registration
NCT07012317
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Status
COMPLETED
Enrollment
50
Start
2025-05-29
Primary completion
2025-11-24
Lead sponsor
Midwest Center for Metabolic and Cardiovascular Research
Conditions
Gastrointestinal Symptoms; Weight Loss; GLP-1
Interventions
OTHER:High Fiber Bar with Inulin; OTHER:High Fiber bar with Fiber Blend; OTHER:High Fiber Bar with Resistant Starch type 4; OTHER:Low Fiber Bar
Results posted
FALSE

Registered primary outcomes

  • Composite GI Symptom Score [Measured on days 1-10, 25-34, 49-58, and 73-82 where day 1 is the virtual visit date and start of the 3-day baseline. Study product consumption begins on day 4, 28, 52, and 76 and continues for 7 days followed by a 14 day washout period.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.